Cyclacel Pharmaceuticals (NASDAQ:CYCC) Now Covered by Analysts at StockNews.com
StockNews.com assumed coverage on shares of Cyclacel Pharmaceuticals (NASDAQ:CYCC – Free Report) in a report issued on Friday morning. The firm issued a sell rating on the biotechnology company’s stock. Separately, Roth Capital lowered Cyclacel Pharmaceuticals from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 23rd. Get Our Latest […]
More Stories
Astika Holdings, Inc. (OTCMKTS:ASKH) Short Interest Update
Astika Holdings, Inc. (OTCMKTS:ASKH – Get Free Report) was the recipient of a significant drop in short interest during the...
RTX Co. (NYSE:RTX) Shares Bought by Quest Partners LLC
Quest Partners LLC boosted its position in shares of RTX Co. (NYSE:RTX – Free Report) by 8,216.2% during the 3rd...
Sirius Real Estate Limited (LON:SRE) Declares Dividend of €0.03
Sirius Real Estate Limited (LON:SRE – Get Free Report) declared a dividend on Monday, November 18th,Upcoming Dividends.Co.Uk reports. Shareholders of...
Vaughan Nelson Investment Management L.P. Sells 157 Shares of AMETEK, Inc. (NYSE:AME)
Vaughan Nelson Investment Management L.P. decreased its position in AMETEK, Inc. (NYSE:AME – Free Report) by 0.1% in the 3rd...
Sutro Biopharma (NASDAQ:STRO) Given Buy Rating at HC Wainwright
Sutro Biopharma (NASDAQ:STRO – Get Free Report)‘s stock had its “buy” rating restated by equities researchers at HC Wainwright in...
Bank of America Issues Pessimistic Forecast for PepGen (NASDAQ:PEPG) Stock Price
PepGen (NASDAQ:PEPG – Get Free Report) had its target price lowered by equities researchers at Bank of America from $10.00...